Agkistin-s, a disintegrin domain, inhibits angiogenesis and induces BAECs apoptosis

J Cell Biochem. 2006 Dec 15;99(6):1517-23. doi: 10.1002/jcb.20859.

Abstract

Previous work in our laboratory has shown agkistin, a snake venom metalloproteases (SVMPs) from the venom of Agkistrodon halys, possesses antiplatelet aggregation activity. In this study, we further examined the antiangiogenic activity of agkistin-s, the disintegrin domain of agkistin. Recombinant agkistin-s was produced in Escherichia coli by subcloning its cDNA into pET28a vector, and the effect of purified agkistin-s was evaluated. At the concentration of 0.5-1.5 microM, the recombinant agkistin-s exhibited inhibitory activities on the bovine aortic endothelial cells (BAECs) migration and proliferation in a dose-dependent manner. In addition, it exhibited an effective antiangiogenic effect when assayed by using the 10-day-old embryo chick CAM model and effectively inhibits the tube-like structure formation. Furthermore, it potently induced BAECs apoptosis as examined by flow cytometric assays.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Cattle
  • Cells, Cultured
  • Chickens
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects*
  • Neovascularization, Pathologic*
  • Recombinant Proteins / pharmacology
  • Viper Venoms / pharmacology*

Substances

  • Recombinant Proteins
  • Viper Venoms
  • agkistin